Menu
Recruiting NCT06974695

Identification of Predictive Factors for Failure of Cholangioscopy-assisted Lithotripsy in the Management of Complex Bile Duct Stones: a Retrospective Study

Observational Bile Duct Stones

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Bile Duct Stones. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Predictive Factors for Cholangioscopy-Assisted Lithotripsy Failure in the Management of Complex Biliary Stones: A Retrospective Analysis

Overview

This study aims to optimize the management of complex biliary stones by identifying predictive factors for SpyGlass lithotripsy failure.

Primary outcome measures

  • Predictive factors for failure of cholangioscopy lithotripsy in the management of complex bile duct stone [Time frame: Baseline]

Eligibility criteria

Inclusion criteria

  • Any adult patient who underwent cholangioscopy-guided lithotripsy for bile duct stones between January 1, 2018, and May 30, 2025

Exclusion criteria

  • Patient who objected to the collection of their data

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

France · 1 center
  • CHRU Brabois Vandoeuvre les Nancy — Vandœuvre-lès-Nancy

Identifiers

NCT: NCT06974695 · 2025_PI_011

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗